2022
DOI: 10.1155/2022/9731987
|View full text |Cite
|
Sign up to set email alerts
|

Central Neurocytoma with Hemorrhagic Presentation Case Report and Review of the Literature

Abstract: Central neurocytoma (CN) is slow-growing rare intraventricular tumor that represents 0.25-0.5% of all intracranial tumors in adults. Typically, it is seen in young adults, yet with surgical resection, it has excellent prognosis. Due to CN rarity and its feature similarities with other common tumors, misdiagnosis can be an issue. With no pathognomonic clinical features of CN, a proper diagnosis can be achieved by radiological imaging, magnetic resonance spectroscopy, histopathology assessment, and immunohistoch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(16 citation statements)
references
References 27 publications
0
16
0
Order By: Relevance
“…Based on the World Health Organization classification, CN is regarded as a low-grade tumor (Grade II) [ 3 ]. CN has no sex-specific predominance [ 2 ]. It frequently afflicts patients in the age group of 20-40 years with a mean age of 30 years [ 3 , 7 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Based on the World Health Organization classification, CN is regarded as a low-grade tumor (Grade II) [ 3 ]. CN has no sex-specific predominance [ 2 ]. It frequently afflicts patients in the age group of 20-40 years with a mean age of 30 years [ 3 , 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…Central neurocytoma (CN) is a benign neuronal tumor that has an intraepithelial origin. It arises from the germinal matrix cells located in the septum pellucidum or the periventricular region [ 1 , 2 ]. CNs are rare and constitute 0.1-0.5% of all brain tumors [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Its pathogenesis is associated with various chromosomal aberrations (7). Mohammad et al revealed that with no characteristic clinical symptoms of CN, a correct diagnosis can be made by radiographic imaging, histopathology assessment, and immunohistochemistry (8). Chang et al analyzed 781 patients with cancer and revealed a 5-year OS rate of 87.2% (9).…”
Section: Discussionmentioning
confidence: 99%
“…A definitive diagnosis can only be made through immunohistochemistry to determine the neuronal origin of the tumor (Sharma et al, 2006). Although it's described that women at a younger age are more likely to have CN compared to men, current consensus suggests that both genders are affected equally (Alsadiq et al, 2022;Li et al, 2012). The tumor mainly affects young adults aged between 20 to 40 years old, with the peak incidence occurring in the third decade (Lee et al, 2016).…”
Section: Introductionmentioning
confidence: 99%